Regeneron Pharmaceuticals (REGN) News Today $563.00 +3.20 (+0.57%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$557.00 -6.00 (-1.07%) As of 04:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Aigen Investment Management LP Decreases Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)1 hour ago | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Entropy Technologies LP1 hour ago | marketbeat.comMizuho Securities USA LLC Has $5.34 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)1 hour ago | marketbeat.comTownsquare Capital LLC Grows Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)1 hour ago | marketbeat.com5 New Dividends in 2025 (Including an 8.8% Yielder)...August 10 at 10:16 PM | marketbeat.comForsta AP Fonden Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 5:50 AM | marketbeat.comNational Bank of Canada FI Has $62.14 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 5:43 AM | marketbeat.comSwiss National Bank Has $193.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 5:31 AM | marketbeat.comMaryland State Retirement & Pension System Trims Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 4:56 AM | marketbeat.comCitizens Financial Group Inc. RI Sells 465 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 4:37 AM | marketbeat.comNew Age Alpha Advisors LLC Trims Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 10 at 4:18 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Lifted by Mitsubishi UFJ Asset Management Co. Ltd.August 9 at 6:18 AM | marketbeat.comDeutsche Bank AG Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 9 at 5:27 AM | marketbeat.comCharles Schwab Investment Management Inc. Has $450.52 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 9 at 5:27 AM | marketbeat.comRegeneron’s Promising Immunotherapy Study for Advanced Lung CancerAugust 9 at 2:10 AM | msn.comCantor Fitzgerald Brokers Lower Earnings Estimates for REGNAugust 8 at 9:04 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Headlands Technologies LLCAugust 8 at 6:52 AM | marketbeat.comASR Vermogensbeheer N.V. Acquires Shares of 9,485 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 8 at 5:48 AM | marketbeat.comVanguard Group Inc. Has $5.97 Billion Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 8 at 5:21 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Goldman Sachs Group Inc.August 8 at 5:10 AM | marketbeat.comBMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps OutperformAugust 8 at 2:09 AM | insidermonkey.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Decreased by Cornerstone Advisors LLCAugust 7, 2025 | marketbeat.comWealthspire Advisors LLC Acquires 3,731 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 7, 2025 | marketbeat.comMutual of America Capital Management LLC Has $7.75 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 7, 2025 | marketbeat.comiA Global Asset Management Inc. Has $12.20 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 6, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Raised by American Assets Inc.August 6, 2025 | marketbeat.comAmerican Assets Investment Management LLC Buys New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 6, 2025 | marketbeat.comING Groep NV Has $13.53 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 6, 2025 | marketbeat.comPNC Financial Services Group Inc. Sells 755 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 6, 2025 | marketbeat.comRoyal Bank Of Canada Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock PriceAugust 6, 2025 | americanbankingnews.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to Issue Quarterly Dividend of $0.88August 5, 2025 | marketbeat.comRegeneron Pharmaceuticals (NASDAQ:REGN) Given New $640.00 Price Target at BMO Capital MarketsAugust 5, 2025 | marketbeat.comRegeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysAugust 5, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Empire Life Investments Inc.August 5, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Sells 2,125 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 5, 2025 | marketbeat.comThese Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected EarningsAugust 4, 2025 | benzinga.comRaiffeisen Bank International AG Acquires 15,105 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 4, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Banco Santander S.A.August 4, 2025 | marketbeat.comTIAA Trust National Association Raises Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 4, 2025 | marketbeat.comAlberta Investment Management Corp Sells 1,614 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 4, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Bank of Nova ScotiaAugust 3, 2025 | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Invests $30.17 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 3, 2025 | marketbeat.com2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top AnalystsAugust 3, 2025 | fool.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Jefferies Financial Group Inc.August 3, 2025 | marketbeat.comCetera Investment Advisers Raises Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 3, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by LPL Financial LLCAugust 3, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2025 Earnings Call TranscriptAugust 2, 2025 | msn.comRegeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Up - Still a Buy?August 2, 2025 | marketbeat.comUNIVEST FINANCIAL Corp Has $11.68 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)August 2, 2025 | marketbeat.comRegeneron (REGN) Q2 EPS Jumps 53%August 2, 2025 | fool.com Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼1.290.48▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼4234▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Moderna News Intellia Therapeutics News Vir Biotechnology News Vertex Pharmaceuticals News AbbVie News Eli Lilly and Company News Merck & Co., Inc. News Pfizer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale